Eleventh of the case studies. The blog has two routes into the collapse — the contemplative practice of the mechanism post, and the designed secular programme. This is the third, and it is the one where the field itself has written the thesis down.
Status. The clinical and survey findings below are published and cited; the reading of them through this series’ model is an inference, offered as one. The post names no researcher as a guru and no participant as a case. As everywhere: a description of a state and its setting is not a finding about anyone’s mind, and nothing here is advice about drugs.
The mechanism post’s collapse needs an approach: attention turned inward, damping lowered, the system brought to a state that cannot report itself and therefore needs a meaning from outside. The contemplative route runs it through practice. The secular route — est, the Forum — runs it through fatigue, rules, and a room.
There is a third, older route, and it is not subtle: a pharmacological one that reaches the same territory in an afternoon. That it is chemical does not change what the series is about. The mechanism post’s claim was never that meditation produces the state — it is that the state is a state, that it is appraisable, and that whoever supplies the appraisal holds the lever.1 A molecule can open the door as well as an hour of sitting can.
What makes this case worth a post is not the pharmacology. It is that the people who study it have already said the thesis out loud, in their own vocabulary, and named the appraisal as the variable that decides everything.
Here is the sentence. It is from the psychedelic-difficulty literature, and every clause of it is the mechanism post:
“Whether a phenomenon is experienced as ‘bad’ or ‘part of the process’ depends on a person’s appraisal. As with meditation experiences, emergent phenomena like depersonalization could be appraised as expected and welcome by some individuals, while others may find them unexpected and unsettling.”2
Read it slowly, because it is doing four things at once. It says the same phenomenon is bad or good. It says the difference is the appraisal. It names depersonalization as the phenomenon — the same state the mechanism post’s meditation finding is about. And it says “as with meditation experiences” — it draws the line between the two routes itself.
This is the series’ entire apparatus, stated by a field that arrived at it from survey data rather than from a control-theoretic model. The blog’s contribution is not the observation that states get appraised — the literature has that.3 It is the longer argument about who the appraiser is and what they get for supplying the reading.
The coercion post’s first lever is a frame supplied before the state arrives. In this literature that lever is not a metaphor — it is a measured independent variable, and it has a name:
“Set and setting.”
The finding is not that psychology is interesting. It is that the difficulty of an experience is predicted by how the person was framed for it and what was around them when it happened. A nationally representative survey of psychedelic users found six variables that predicted difficulty, and every one is a framing variable:4
| the predictor | what it is, in this series’ terms |
|---|---|
| no preparation | no frame supplied in advance |
| negative mindset | a frame supplied in advance, pointing the wrong way |
| no psychological support | no holder |
| disagreeable physical environment | milieu control, inverted |
| dose too large | the approach driven past the edge |
| a major life event beforehand | the pre-existing vulnerability the selection criteria of the coercion post look for |
Six for six. The coercion post lists the levers a group supplies deliberately; this literature lists the same variables as risk factors.
Schematic — an illustration of the argument in §2–§3, not a measurement. The readings and predictors are as the literature states them.
The group and the clinic are naming the same things, and the only difference is intention and invoice. That is the Costume’s finding again: the levers are positions, and they show up as risk factors in a benign setting and as technique in a coercive one.
The series has to keep this at its honest size, so here are the numbers and not a mood.
The mixed-methods study above gathered 608 people who reported difficulties extending past the experience itself — weeks, months, years. The most common forms were anxiety and fear, existential struggle, social disconnection, and depersonalization and derealization. For about a third, the problems lasted more than a year; for about a sixth, more than three years.2 Other surveys point the same way: in the 2020 Global Drug Survey, 22.5% of LSD/psilocybin users reported at least one negative outcome, most often “mental confusion, memory problems, or racing thoughts”; in the Global Ayahuasca survey, 12% reported lasting adverse effects for which they sought professional help.2
Two things about those numbers matter to this series and one of them is easy to miss.
First, the state that is hardest to see is the one that appears here by name: depersonalization. It is not a rare curiosity of the psychedelic literature; it is a listed category of the difficulty — 95 of the 608, about 16%.2 The mechanism post argued that this state hides from self-report and is appraised as good. Both claims are visible in this dataset.
Second, the good outcome and the bad outcome are the same state, and what separates them is the reading. A study of long-term negative psychological outcomes and the studies of “healing” and “mystical-type” experiences are studying the same events, and the difference is the appraisal — the field says so.2
If the frame is a variable, the person who supplies it is a role, and this field has been arguing for years about who should hold it.
Set and setting implies a guide: the one who prepares the frame before, and who is present during and after — the holder the model requires. In the traditional and clinical forms that is a curandero, a sitter, a therapist, a study team. And the literature’s harm-reduction guidance is, in exactly the series’ terms, about making that role accountable: preparation, informed consent, a safe setting, someone responsible.5
Now hold that against the case studies. The certified frame found a host culture granting authority to a teacher it had not checked. The sanctioned trance found a state pre-legitimised by ceremony, with no alarm wired to it. The psychedelic field’s answer to both is the same as the series’ countermeasure — name the role, and make it answerable — which is why its harm-reduction literature reads as the responsible version of the same structure.
This is the case where the counterweight is largest, so it goes first and not last.
The therapeutic claims are real and studied. Psilocybin occasioned mystical-type experiences that are among the strongest predictors of long-term benefit in the clinical trials, and those experiences are not incidental — they are the treatment’s proposed mechanism.6 For many participants the same class of experience is reported as healing, including where it is hard: the confrontation with trauma is “unsurprisingly, challenging but nonetheless ultimately experienced as healing.”2
And the same field that reports the benefits is the field that documented the harms — the 608-person study above, the difficulty literature, the harm-reduction work. That is the self-correcting structure the label post argued for, operating as advertised. The honest reading is not “this is dangerous”: it is that a practice can be genuinely therapeutic and genuinely capable of harm, and that what sorts the two is the same variable in both — the frame, and presence of someone accountable to hold it.
And this is not advice. The series’ standing non-use clause applies at full strength: nothing here is a statement about any individual’s state, a recommendation about any substance, or grounds to override anyone’s account of their own experience. It is a reading of a structure.
Three routes, one mechanism, and now a field that has put the appraisal on a survey instrument.
| contemplative | designed | pharmacological | |
|---|---|---|---|
| the approach | inward attention | fatigue, rules, confrontation | a molecule |
| the state | the collapse | the same collapse, by the clock | the same territory, in an afternoon |
| the appraisal | awakening; depersonalization | Transformation | breakthrough — or bad trip |
| who supplies it | a teacher, a tradition | a company | set and setting, and the guide |
| the field’s own word for the lever | — | — | appraisal |
The last row is the finding. The contemplative and commercial cases had to have the appraisal argued into them by this series. Here the field names it as the decisive variable, and then names the unframed version of the same state as the harm.
Which is the end of the arc the three induction posts have been running. The mechanism does not care whether the door is opened by attention, by exhaustion, or by a molecule. What it cares about — what the whole series is about — is who is standing on the far side of the door when it opens, and what they call what they find. A field that has learned to call it appraisal, and to insist on preparation and a responsible sitter, has arrived at the series’ countermeasure from the practice side: supply a frame you can be held to, and be there for what comes through.
Marking: documented — the survey and mixed-methods findings, the durations, the set-and-setting predictors, the appraisal passage, and the therapeutic literature. Argument — that the psychedelic route is the mechanism’s third induction path; that “set and setting” is the frame lever documented as a variable; that the field’s harm-reduction guidance is the series’ countermeasure from the practice side. The reading is the post’s contribution, and §4 states the scope at its honest size.
The mechanism these routes reach — the mechanism post — and the appraisal lever the group exploits, the coercion post. The psychedelic literature’s “appraisal” is the same variable this series calls the frame; the extension from a state to a structure of authority is the series’.↩︎
On extended difficulties following psychedelic use — Evans, J., Robinson, O. C., Argyri, E. K., Suseelan, S., Murphy-Beiner, A., McAlpine, R., Luke, D., Michel, K., & Prideaux, E. (2023), “Extended difficulties following the use of psychedelic drugs: A mixed methods study,” PLoS ONE 18(10): e0293349 — the mixed-methods study of 608 participants reporting difficulties persisting past the experience: the most common forms (anxiety and fear; existential struggle; social disconnection; depersonalization and derealization — the depersonalization/dissociation sub-theme reported by 95 participants, ~16%); the durations (about a third beyond a year, about a sixth beyond three years); the appraisal passage (“Whether a phenomenon is experienced as ‘bad’ or ‘part of the process’ depends on a person’s appraisal. As with meditation experiences, emergent phenomena like depersonalization could be appraised as expected and welcome by some individuals, while others may find them unexpected and unsettling.”); and the survey figures the study reports (Global Drug Survey 2020 — Kopra et al., J. Psychopharmacol. 2023: 22.5% of LSD and psilocybin users at least one negative outcome; Global Ayahuasca Survey — Bouso et al. 2022: 12% seeking professional support for lasting adverse effects). https://pmc.ncbi.nlm.nih.gov/articles/PMC10597511↩︎
On appraisal as a meaning-making process — Gashi, L., Sandberg, S., & Pedersen, W. (2021), “Making ‘bad trips’ good: How users of psychedelics narratively transform challenging trips into valuable experiences,” International Journal of Drug Policy 87: 102997 — the interviews showing that a difficult experience is re-read through narrative after the fact, so that the account a person gives of their experience is in part a product of its later telling. https://doi.org/10.1016/j.drugpo.2020.102997↩︎
The six set-and-setting variables associated with a greater degree of difficulty — Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W., & Goldberg, S. B. (2023), “Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics,” Journal of Affective Disorders 326: 105–110 — from a nationally representative US survey (N = 2,822; the subsample of n = 613 reporting lifetime classic psychedelic use): no preparation; disagreeable physical environment; negative mindset; no psychological support; dose too large; a major life event prior to the experience. (The 608-participant study above summarises these as “six” but then lists seven, adding “disagreeable social environment”; the six here are as the primary source states them.) https://doi.org/10.1016/j.jad.2023.01.073 · https://pmc.ncbi.nlm.nih.gov/articles/PMC9974873↩︎
On set and setting as harm reduction — its treatment as a practical framework for reducing harm (preparation, setting, support, the role of the guide). https://pubmed.ncbi.nlm.nih.gov/39080241 · and the history of the concept, https://pubmed.ncbi.nlm.nih.gov/35818775↩︎
On mystical-type experience as the predictor of benefit — Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D., & Jesse, R. (2008), “Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later,” J. Psychopharmacol. 22(6): 621–632 — the mystical experience measured on the session day accounting for the later ratings of personal meaning and spiritual significance; and Griffiths, R. R., et al. (2018), “Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors,” J. Psychopharmacol. 32(1): 49–69. https://pmc.ncbi.nlm.nih.gov/articles/PMC3050654 · https://doi.org/10.1177/0269881117731279↩︎